Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05504681 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Integration of Neurocognitive Biomarkers Into a Neuro-Oncology Clinic

StatusRecruiting
PhaseNot specified
Started2021-11-30
View on ClinicalTrials.gov ↗

Amendment history

2026-05-18
Study Status v10
Primary completion pushed: 2026-04 → 2030-04
Completion pushed: 2027-11 → 2032-04
2026-02-13
Study Status v9
Primary completion date2026-01→2026-04
2025-11-13
Study Status v8
Primary completion date2025-11→2026-01
2024-10-17
Study Status, Contacts/Locations v7
Re-verified, no change to tracked fields
2024-05-21
Study Status v6
Start date2021-11-03→2021-11-30
Show 5 earlier versions
2023-12-26
Study Status, Contacts/Locations v5
Primary completion date2023-11→2025-11
Completion date2025-11→2027-11
2023-09-08
2 amendments v3-v4
2 re-verifications since 2023-08-22, no change to tracked fields
2023-02-15
Study Status v2
Primary completion date2023-02-03→2023-11
Completion date2025-02-03→2025-11
2022-09-30
Study Identification, Study Status v1
Study title+47 characters
BrainlabIntegration Cognitionof AppNeurocognitive Biomarkers Into a Neuro-Oncology Clinic
2022-08-15
Original filing
This is prospective observational registry study that will assess 1) if the neurocognitive function app (Brainlab Cognition) can be used in a widespread neuro-oncology clinic setting and 2) if patient reported quality of life parameters can be obtained electronically and integrated into clinic.
Trial Details
NCT Number NCT05504681
Lead Sponsor Baptist Health South Florida
Collaborators: Brainlab AG
Conditions Neurocognitive Disorders
Enrollment 200 participants
Start Date 2021-11-30
Primary Completion 2030-04 (estimated)
Study Completion 2032-04 (estimated)
Updated on ClinicalTrials.gov 2026-05-19